<DOC>
	<DOCNO>NCT01477970</DOCNO>
	<brief_summary>The possibility prevent early ovarian hyperstimulation syndrome ( OHSS ) double daily dose GnRH-antagonist woman stimulate antagonist protocol risk OHSS evaluate . Thirty-eight woman study group underwent ovarian stimulation use GnRH-antagonist protocol might cycle cancel OHSS compare 76 woman control group . All case study group IVF woman present rapid rise E2 ≥ 3500 pg/ml 7th day stimulation later follicle ( &gt; 12mm ) &gt; 15 total big one ≤ 16mm diameter . By decrease rFSH dose 100IU day add additional dose GnRH-antagonist ( 0.25 twice day ) , estradiol level lower reach plateau hCG give . A marked decrease plateau estradiol level observe day oocyte retrieval pregnancy rate adversely affect compare optimum ovarian response cycle . None woman cancel developed OHSS . In overresponding IVF cycle , double usual GnRH-antagonist daily-dose ovarian stimulation , estradiol rise could block minimal follicular stimulation may continue without risk OHSS adversely affect pregnancy rate .</brief_summary>
	<brief_title>Double GnRH Antagonist Daily Dose Hyperresponding IVF/ICSI Cycles May Prevent OHSS</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<criteria>Women stimulate antagonist protocol risk ovarian hyperstimulation syndrome Has choose preventive protocol ( coast and/or cryopreservation ) exclude</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>GnRH antagonist</keyword>
	<keyword>OHSS</keyword>
	<keyword>ovarian stimulation</keyword>
</DOC>